In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics.

New for 2024, our expert speaker will engage with the audience in real-time, addressing questions on various aspects of microplastics science and research .

Alzheimer’s disease (AD) is the most common form of dementia in the elderly population. While several peptide and protein biomarkers in cerebrospinal fluid (CSF) have been used for AD diagnosis, an unequivocal diagnosis in the early phases of AD is still lacking.

Advances in automation, digitization and data modeling are changing how labs are built and run from the ground up. Hear about the technologies helping to drive digital transformation and laboratory efficiencies.

Generating a highly expressing, regulatory compliant clonal cell line is key when developing a biopharmaceutical. Yet cell line development is labor-intensive, time consuming and costly.

The production of a high-quality and productive cell line requires both an expression system which yields high expressing clones and a workflow which allows selection of the highest producing clones.

In this webinar, you’ll discover how combining a single-cell analysis platform with a novel glutamine synthetase-Chinese hamster ovary (GS-CHO) expression system can yield highly productive, scalable, clonal cell lines for developing biopharmaceuticals.

An incredible opportunity to ask Andy Shovel, the Co-CEO of THIS absolutely anything about his career, life or the future of foods.